Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-25T05:56:14.106Z Has data issue: false hasContentIssue false

Comprehensive mutational analysis of the TSC1 gene: observations on frequency of mutation, associated features, and nonpenetrance

Published online by Cambridge University Press:  01 July 1998

J. KWIATKOWSKA
Affiliation:
Division of Experimental Medicine and Medical Oncology, Brigham and Women's Hospital, Boston, MA 02115, U.S.A.
S. JOZWIAK
Affiliation:
Department of Child Neurology, Children's Memorial Hospital, Warsaw, Poland
F. HALL
Affiliation:
Division of Experimental Medicine and Medical Oncology, Brigham and Women's Hospital, Boston, MA 02115, U.S.A.
E. P. HENSKE
Affiliation:
Division of Experimental Medicine and Medical Oncology, Brigham and Women's Hospital, Boston, MA 02115, U.S.A.
J. L. HAINES
Affiliation:
Program in Genetics, Vanderbilt University, Nashville, TN, U.S.A.
P. McNAMARA
Affiliation:
Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, MA, U.S.A.
J. BRAISER
Affiliation:
Division of Experimental Medicine and Medical Oncology, Brigham and Women's Hospital, Boston, MA 02115, U.S.A.
J. WIGOWSKA-SOWINSKA
Affiliation:
Department of Developmental Neurology, University of Medical Sciences, Poznan, Poland
J. KASPRZYK-OBARA
Affiliation:
Department of Child Neurology, Children's Memorial Hospital, Warsaw, Poland
M. P. SHORT
Affiliation:
American Medical Association, Wacker Drive, Chicago, IL, U.S.A.
D. J. KWIATKOWSKI
Affiliation:
Division of Experimental Medicine and Medical Oncology, Brigham and Women's Hospital, Boston, MA 02115, U.S.A.
Get access

Abstract

We performed a comprehensive analysis for mutations in the TSC1 gene using Southern blot analysis, and SSCP and heteroduplex analysis of amplified exons in 13 families with genetic linkage to the TSC1 region, 22 small families without linkage information, and 126 sporadic patients. 17 unique mutations were identified in 21 patients. Mutations were found in 7/13 (54%) TSC1-linked families, 1/22 (5%) small families without linkage, and 13 of 126 (10%) sporadic cases. The mutations were all chain-terminating, with 14 small deletions, 1 small insertion, and 6 nonsense mutations. In families with mutations, all individuals carrying a mutation met formal diagnostic criteria for TSC, apart from a 3-year-old girl who had inherited a deletion mutation, and who had no seizures, normal intelligence, normal abdominal ultrasound, and hypomelanotic macules only on physical exam. We assessed the incidence and severity of mental retardation in the 13 sporadic patients with TSC1 mutations versus the entire sporadic cohort, and found no significant difference. The observations indicate that TSC1 mutations are all inactivating, suggest that TSC1 disease occurs in only 15–20% of the sporadic TSC population, and demonstrate that presymptomatic TSC does occur.

Type
Research Article
Copyright
© University College London 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)